Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile

Nicole Le Corre, Katia Abarca, Patricio Astudillo, Marcela Potin, Sofía López, Macarena Goldsack, Vania Valenzuela, Andrea Schilling, Victoria Gaete, Lilian Rubio, Mario Calvo, Loreto Twele, Marcela González, Daniela Fuentes, Valentina Gutiérrez, Felipe Reyes, Lorena I. Tapia, Rodolfo Villena, Angello Retamal-Díaz, Antonio CárdenasEduardo Alarcón-Bustamante, Xing Meng, Qianqian Xin, José V. González-Aramundiz, María Javiera Álvarez-Figueroa, Pablo A. González, Susan M. Bueno, Jorge A. Soto, Cecilia Perret, Alexis M. Kalergis

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds